Opal Capital’s Idexx Laboratories IDXX Stock Holding History

Opal Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.85M	Buy	7,304 +1,846	+34%	+$1.04M	0.69%	52
2026 Q1	$3.07M	Buy	+5,458	New	+$3.5M	0.54%	74

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Opal Capital's IDXX Position: Q2 2026 in Review

Opal Capital increased its Idexx Laboratories (IDXX) stake by 34% in Q2 2026, buying an estimated $1.04M and bringing the position to 7,304 shares worth $3.85M. The position accounts for 0.69% of the portfolio, ranked #52.

Opal Capital first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Opal Capital held 7,304 shares of Idexx Laboratories worth $3.85M as of Q2 2026.
Opal Capital bought 1,846 Idexx Laboratories shares in Q2 2026, an estimated $1.04M.
Idexx Laboratories made up 0.69% of Opal Capital's portfolio in Q2 2026, its #52 holding.
Opal Capital first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Opal Capital's 13F filing for Q2 2026, filed 5 Aug 2026.